Roche has announced a definitive agreement to acquire Poseida Therapeutics, a clinical-stage biopharmaceutical company ...

Roche has shared updated findings from the global Phase III SKYSCRAPER-01 study, a critical investigation into the efficacy ...

FDA has approved imatinib (IMKELDI), the first oral liquid tyrosine kinase inhibitor for treating leukemia and a range of cancers, including CML, GIST, and Ph+ ALL. Developed by Shorla Oncology ...

AI-Enabled Drug Discovery is on the verge of a new revolution, with the first data emerging from exciting research indicating ...

The groundbreaking results of the OVATION 2 Study demonstrated a substantial 35% improvement in overall survival, equating to ...

The U.S. Food and Drug Administration (FDA) has approved revumenib, a pioneering drug for relapsed or refractory acute ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii), a novel therapy for ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...